Infection Prevention and Control: Risk Recognition and Communication

March 28, 2021
Registration


Click here to register.

For questions, please email Autumn McGill.
 

Target Audience

Interested healthcare providers.

Description

The Iowa Chapter of the American Academy of Pediatrics is bringing the healthcare team more information about infection prevention and control. This program seeks to inform participants about routes of general infection, prevention, and mitigation during the COVID-19 pandemic. Healthcare providers need to be equipped with the knowledge to properly treat patients with infection, especially COVID-19. More information on transmission and mitigation will equip healthcare providers with the necessary tools to provide high-quality patient care.

Learning Objectives

  • Describe routes of general infection transmission and discuss COVID-19 transmission.
  • Discuss infection prevention and control transmission precautions and additional practices recommended during the COVID-19 pandemic.
  • Identify ways to mitigate the risk of infection transmission among the health care community.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credits
  • 1.00 AOA Category 2­A
  • 1.00 CE Contact Hour(s)
  • 1.00 IBON
Course opens: 
03/28/2021
Course expires: 
03/28/2021
Event starts: 
03/28/2021 - 7:00pm
Event ends: 
03/28/2021 - 8:00pm
Cost:
$0.00
Rating: 
0

Ashlesha Kaushik, MD, FAAP
Medical Director, Pediatric Infectious Diseases and Director, Antimicrobial Stewardship Program, UnityPoint Health - St. Luke's
Clinical Assistant Professor of Pediatrics,  University of Iowa Carver College of Medicine

Dr. Kaushik is an American Academy of Pediatrics (AAP) national spokesperson, member of Iowa American Academy of Pediatrics Board of Directors, and recipient of 2019 Centers for Disease Control and Prevention (CDC) Childhood Immunization Champion Award for Iowa. Dr. Kaushik is AAP Iowa Chapter Immunization representative, AAP Iowa Chapter Infectious Diseases Champion, and serves on Iowa AAP Legislative Committee and IA AAP Committee on Immunization. She is also a featured global health expert for Sabin Vaccine Institutes Immunization Advocates. As AAP Iowa Chapter Immunization Representative, Dr. Kaushik has been at the forefront of AAP efforts toward building of the Iowa immunization coalition-IA Immunizes and is the chair of the coalition scientific advisory committee and serves on the coalition steering committee. Dr. Kaushik is presently serving as national expert faculty for CDC Project Firstline/American Academy of Pediatrics Infection Prevention and Control ECHO (AAP IPC ECHO) provider education program, designed to virtually provide specialist education about COVID-19 to providers across the nation.

Dr. Kaushik completed her postdoctoral fellowship in Pediatric Infectious Diseases at University of Texas Southwestern, Children’s Medical Center of Dallas, Texas. She pursued her residency in Pediatrics from Mount Sinai School of Medicine St. Joseph's Children's Hospital, NJ and received the Best Teaching Resident award for outstanding teaching in Pediatrics. Dr. Kaushik received her postgraduate certification in Pediatrics Leadership from Harvard Medical School and is a Harvard University alumnus. Dr. Kaushik is certified in Healthcare Epidemiology and Infection Control by the Society of Healthcare Epidemiology of America (SHEA). She is a nominated member of the Midwest Society for Pediatric Research, New York Academy of Medicine and an elected overseas fellow of the Royal Society of Medicine, United Kingdom. She has been recently recognized as an honorary Rosalind Member of London Journals Press, United Kingdom. Dr. Kaushik has published her scholarly work in several peer reviewed journals, presented her research at premier national and international conferences, and serves as a reviewer/ editorial board member for prestigious journals. Among her publications, her research-work on impact of MRSA Surveillance in the NICU has been cited by the World Health Organization guidelines on infection control and her recent publication on SARS-COV-2 associated Multisystem inflammatory syndrome in children (MIS-C) has been included among the “top 20 most popular articles” in Pediatric Infectious Disease Journal, included as a key reference in UpToDate chapter- Coronavirus disease 2019 (COVID-19): Multisystem inflammatory syndrome in children (MIS-C) management and outcome [UpToDate is the clinical decision support resource accessed by more than 1.3 million clinicians worldwide] and cited internationally as the base reference for pediatric guidance on MIS-C in Indian Academy of Pediatrics MIS one pager guidance. As an enthusiastic advocate for children’s health, Dr. Kaushik has been consistently involved in community education through numerous media/news stories.

Full biography

Accreditation Statements

  • MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the IMS. DMU is accredited by the IMS to provide continuing medical education for physicians. DMU designates this live activity for 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
  • Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit awarded.​
  • Other healthcare providers: This live activity is designated for 1.0 AMA PRA Category 1 Credit(s)™.

EDUCATIONAL GRANTS

No commercial interest company provided financial support for this continuing education activity.

DISCLOSURE

The speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director.

Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with commercial interest companies to disclose.

  • Michelle Dekker, CAE, CMP, activity director
  • Ashlesha Kaushik, MD, FAAP, speaker
  • Autumn McGill, activity coordinator

Disclaimer

Project Firstline is a national collaborative led by the U.S. Centers for Disease Control and Prevention (CDC) to provide infection control training and education to frontline healthcare workers and public health personnel. AAP is proud to partner with Project Firstline, as supported through Cooperative Agreement CDC-RFA-OT18-1802. CDC is an agency within the Department of Health and Human Services (HHS). The contents of this program do not necessarily represent the policies of CDC or HHS and should not be considered an endorsement by the Federal Government.

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.

Available Credit

  • 1.00 AMA PRA Category 1 Credits
  • 1.00 AOA Category 2­A
  • 1.00 CE Contact Hour(s)
  • 1.00 IBON

Price

Cost:
$0.00
Please login or Create an Account to take this course.

Click here to register.

For questions, please email Autumn McGill.